These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20212194)

  • 1. Intravitreous dexamethasone effects on different patterns of diabetic macular edema.
    Kuppermann BD; Chou C; Weinberg DV; Whitcup SM; Haller JA; Blumenkranz MS;
    Arch Ophthalmol; 2010 May; 128(5):642-3. PubMed ID: 20212194
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant.
    Lazic R; Lukic M; Boras I; Draca N; Vlasic M; Gabric N; Tomic Z
    Retina; 2014 Apr; 34(4):719-24. PubMed ID: 23975006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients.
    Boyer DS; Faber D; Gupta S; Patel SS; Tabandeh H; Li XY; Liu CC; Lou J; Whitcup SM;
    Retina; 2011 May; 31(5):915-23. PubMed ID: 21487341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical coherence tomography.
    Kumar A; Sinha S
    Ophthalmology; 2008 Feb; 115(2):417-8; author reply 418. PubMed ID: 18243920
    [No Abstract]   [Full Text] [Related]  

  • 5. Diffuse diabetic macular oedema treated with intravitreal bevacizumab or triamcinolone acetonide.
    Rensch F; Spandau UH; Wickenhäuser A; Jonas JB
    Acta Ophthalmol; 2010 Mar; 88(2):e36-7. PubMed ID: 19210330
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravitreal dexamethasone for diabetic macular edema: a pilot study.
    Chan CK; Mohamed S; Lee VY; Lai TY; Shanmugam MP; Lam DS
    Ophthalmic Surg Lasers Imaging; 2010; 41(1):26-30. PubMed ID: 20128566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema.
    Campochiaro PA; Brown DM; Pearson A; Ciulla T; Boyer D; Holz FG; Tolentino M; Gupta A; Duarte L; Madreperla S; Gonder J; Kapik B; Billman K; Kane FE;
    Ophthalmology; 2011 Apr; 118(4):626-635.e2. PubMed ID: 21459216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal injection of triamcinolone for diffuse diabetic macular edema.
    Chan CK; Chan WM; Cheung BT; Yuen CY; Lee VY; Lam DS
    Arch Ophthalmol; 2004 Jul; 122(7):1083-5; author reply 1086-8. PubMed ID: 15249387
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial.
    Pearson PA; Comstock TL; Ip M; Callanan D; Morse LS; Ashton P; Levy B; Mann ES; Eliott D
    Ophthalmology; 2011 Aug; 118(8):1580-7. PubMed ID: 21813090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal injection of triamcinolone acetonide for diabetic macular edema.
    Kuhn F; Barker D
    Arch Ophthalmol; 2004 Jul; 122(7):1082-3; author reply 1086-8. PubMed ID: 15249385
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Ho TC; Lai WW; Lam DS
    Am J Ophthalmol; 2006 Apr; 141(4):786-7; author reply 787-8. PubMed ID: 16564847
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Sarici A; Muftuoglu G
    Am J Ophthalmol; 2006 Apr; 141(4):785-6; author reply 786. PubMed ID: 16564845
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation of visual acuity and macular thickness measured by optical coherence tomography in patients with persistent macular edema.
    Blumenkranz MS; Haller JA; Kuppermann BD; Williams GA; Ip M; Davis M; Weinberg DV; Chou C; Whitcup SM
    Retina; 2010; 30(7):1090-4. PubMed ID: 20616686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone intravitreal implant for treatment of patients with persistent diabetic macular edema.
    Dutra Medeiros M; Postorino M; Navarro R; Garcia-Arumí J; Mateo C; Corcóstegui B
    Ophthalmologica; 2014; 231(3):141-6. PubMed ID: 24356099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal triamcinolone in diabetic macular edema.
    Aslam S; Malik N; Davies N
    Arch Ophthalmol; 2006 Oct; 124(10):1506-7; author reply 1507. PubMed ID: 17030730
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetic macular edema.
    Narula R; Agarwal M; Chaudhary SP; Shroff C
    Ophthalmology; 2009 Sep; 116(9):1833-4; author reply 1834. PubMed ID: 19729104
    [No Abstract]   [Full Text] [Related]  

  • 17. Comment on the article by Dutra Medeiros et al. entitled 'dexamethasone intravitreal implant for treatment of patients with persistent diabetic macular edema'.
    Arıkan Yorgun M; Toklu Y
    Ophthalmologica; 2015; 233(2):117-8. PubMed ID: 25613004
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravitreal dexamethasone implant in patients with persistent diabetic macular edema.
    Zucchiatti I; Lattanzio R; Querques G; Querques L; Del Turco C; Cascavilla ML; Bandello F
    Ophthalmologica; 2012; 228(2):117-22. PubMed ID: 22310491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
    Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
    Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic macular edema.
    Kim SJ
    Ophthalmology; 2009 Jun; 116(6):1228.e1; author reply 1228-9. PubMed ID: 19486803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.